Covered recipient · General Payments record
ERIN MCGEE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,874.69
- Reported across 61 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $456.20 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Dermavant Sciences, Inc. | $124.84 | 1 |
| Verrica Pharmaceuticals Inc. | $75.56 | 2 |
| ABBVIE INC. | $64.80 | 3 |
| Arcutis Biotherapeutics, Inc. | $48.81 | 2 |
| Almirall LLC | $40.21 | 2 |
| Amgen Inc. | $38.72 | 2 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $24.62 | 1 |
| GENZYME CORPORATION | $24.06 | 1 |
| Galderma Laboratories, L.P. | $14.58 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.83 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107630185 | CMS |
| ABBVIE INC. | $22.66 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107630187 | CMS |
| ABBVIE INC. | $16.31 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107630189 | CMS |
| Almirall LLC | $20.18 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120639966 | CMS |
| Almirall LLC | $20.03 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120640012 | CMS |
| Amgen Inc. | $19.12 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117625376 | CMS |
| Amgen Inc. | $19.60 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117625378 | CMS |
| Arcutis Biotherapeutics, Inc. | $24.27 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121094241 | CMS |
| Arcutis Biotherapeutics, Inc. | $24.54 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121094243 | CMS |
| Dermavant Sciences, Inc. | $124.84 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127995836 | CMS |
| Galderma Laboratories, L.P. | $14.58 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145374679 | CMS |
| GENZYME CORPORATION | $24.06 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139780392 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $24.62 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152232775 | CMS |
| Verrica Pharmaceuticals Inc. | $51.40 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118394658 | CMS |
| Verrica Pharmaceuticals Inc. | $24.16 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118394660 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.